Graphical Abstract 1 Introduction The pursuit of a disease-modifying therapy for Alzheimers disease (AD) has extended over several decades, resulting in numerous unsuccessful clinical trials in this field
Modulating effect of glutamine on IL-1beta-induced cytokine production by human gut
2, Supplemental Material 1, Figure S1) was registered at www.clinicaltrials.gov under number NCT04946526 and approved by the Institutional Review Board of Appalachian State University (protocol number # 21-02216) where all interventions were conducted and samples were collected
Our Mission Health is something that always takes first priority
The grapes were pressed in a nitrogen-saturated hand-press and the must was collected in a bottle also saturated with N 2
2017;53:1 Guzman-Parra J, Streit F, Forstner AJ, Strohmaier J, Gonzlez MJ, Gil Flores S, et al